Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1626878 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $2.24Day −0.44%Mkt cap $69M1Y −22.8%Off 52W high −38.0%Vol (1Y) 47.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,838 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.9% of sh out |
| Days to cover7.2d |
| 13F net flow (QoQ)−0.87% |
| Top-10 13F concentration77.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$40.2M |
| ROE−28.2% |
| ROIC−360.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−6.3% |
| 1Y−22.8% |
| 3Y−55.5% |
| 5Y−86.2% |
| 10Y−81.8% |
| Since incept. (ann.)−17.6% |
Total return through 2026-07-30 · series begins 2015-04-15. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)47.4% |
| Ann. volatility (3Y)66.9% |
| Sharpe (1Y)−0.29 |
| Sharpe (3Y)−0.07 |
| Max drawdown (1Y)−39.4% |
| Max drawdown (3Y)−78.6% |
| Beta (3Y vs SPY)0.97 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 293,104 | $688,795 | 0.96% | +1.5% |
| GEODE CAPITAL MANAGEMENT, LLC | 231,020 | $543,173 | 0.76% | +4.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 200,971 | $472,282 | 0.66% | new |
| RBF Capital, LLC | 198,501 | $466,477 | 0.65% | −50.0% |
| MORGAN STANLEY | 165,554 | $389,052 | 0.54% | +1.3% |
| MILLENNIUM MANAGEMENT LLC | 105,540 | $248,019 | 0.35% | −22.1% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 98,447 | $231,350 | 0.32% | +9.9% |
| VANGUARD FIDUCIARY TRUST CO | 91,576 | $215,204 | 0.30% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2023-12-31 | 2024-03-15 | — | — | $0 | −100.0% |
| 2023-09-30 | 2023-11-09 | — | — | $0 | −100.0% |
| 2023-06-30 | 2023-08-11 | — | — | $0 | −100.0% |
| 2023-03-31 | 2023-05-10 | — | — | $0 | −100.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
